Enveric Biosciences Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 26

Employees

  • Stock Symbol
  • ENVB

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $0.84
  • (As of Friday Closing)

Enveric Biosciences General Information

Description

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

Contact Information

Website
www.enveric.com
Formerly Known As
Spatializer Audio Laboratories, Ameri Holdings, Ameri100, Ameri Holdings, Inc.
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Corporate Office
  • 4851 Tamiami Trail North
  • Suite 200
  • Naples, FL 34103
  • United States
+1 (239) 000-0000

Enveric Biosciences Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enveric Biosciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.84 $0.90 $0.65 - $6.98 $6.13M 7.29M 4.63M -$6.42

Enveric Biosciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 5,006 (1,249) (16,028) 12,016
Revenue 0 0 0 0
EBITDA (14,665) (16,858) (19,517) (55,740)
Net Income (15,078) (17,311) (18,504) (48,977)
Total Assets 8,850 4,300 19,553 26,719
Total Debt 0 0 64 176
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Enveric Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enveric Biosciences‘s full profile, request access.

Request a free trial

Enveric Biosciences Patents

Enveric Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230255900-A1 Compositions for topical treatment of radiation dermatitis Pending 11-Feb-2022 000000000 0
US-11660348-B1 Cannabinoid conjugate molecules Active 01-Feb-2022 000000000 00
US-11883499-B2 Cannabinoid conjugate molecules Active 01-Feb-2022 0000000000 00
US-20230039887-A1 Compositions for topical treatment of radiation dermatitis Inactive 20-Jul-2021 A61K9/0014 0

Enveric Biosciences Executive Team (16)

Name Title Board Seat Contact Info
Joseph Tucker Ph.D Chief Executive Officer
Brent Kelton Chief Executive Officer
Kevin Coveney Chief Financial Officer
Barry Kostiner Chief Financial Officer
Peter Facchini Executive
You’re viewing 5 of 16 executive team members. Get the full list »

Enveric Biosciences Board Members (10)

Name Representing Role Since
000 00000 Enveric Biosciences Founder & Executive Chairman 000 0000
000000000 0000000 Self Board Member 000 0000
0000000 0000 00 Self Board Member 000 0000
000000 000000 Enveric Biosciences Board Member 000 0000
000000 000000 00.0 Enveric Biosciences Chief Executive Officer 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Enveric Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enveric Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Enveric Biosciences‘s full profile, request access.

Request a free trial

Enveric Biosciences Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MagicMed Industries 16-Sep-2021 0000000000 000.00 Drug Discovery 00000 000
Jay Pharma 30-Dec-2020 0000000000 Pharmaceuticals
ATCG Solutions 10-Mar-2017 0000000000 00.00 IT Consulting and Outsourcing
Bigtech Software 23-Sep-2016 0000000000 00000 Business/Productivity Software
DC&M Partners 01-Aug-2016 Merger/Acquisition 000.00 Consulting Services (B2B)
You’re viewing 5 of 10 acquisitions. Get the full list »

Enveric Biosciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Ameri100 Virtuoso 25-Jul-2016 000000000000000000 00.000 Completed
  • 0000000 0000000000
To view Enveric Biosciences’s complete exits history, request access »

Enveric Biosciences FAQs

  • When was Enveric Biosciences founded?

    Enveric Biosciences was founded in 1994.

  • Who is the founder of Enveric Biosciences?

    Dev Nidhi is the founder of Enveric Biosciences.

  • Who is the CEO of Enveric Biosciences?

    Joseph Tucker Ph.D and Brent Kelton are the CEOs of Enveric Biosciences.

  • Where is Enveric Biosciences headquartered?

    Enveric Biosciences is headquartered in Naples, FL.

  • What is the size of Enveric Biosciences?

    Enveric Biosciences has 26 total employees.

  • What industry is Enveric Biosciences in?

    Enveric Biosciences’s primary industry is Drug Discovery.

  • Is Enveric Biosciences a private or public company?

    Enveric Biosciences is a Public company.

  • What is Enveric Biosciences’s stock symbol?

    The ticker symbol for Enveric Biosciences is ENVB.

  • What is the current stock price of Enveric Biosciences?

    As of 17-May-2024 the stock price of Enveric Biosciences is $0.84.

  • What is the current market cap of Enveric Biosciences?

    The current market capitalization of Enveric Biosciences is $6.13M.

  • What is Enveric Biosciences’s annual earnings per share (EPS)?

    Enveric Biosciences’s EPS for 12 months was -$6.42.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »